
comprehensive goals met in MassBio’s Diversity, Equity and Inclusion (DE&I) public pledge

social enterprises supported through Acumen America’s Health Equity portfolio

of scope 1 and 2 Greenhouse
Gas (GHG) emissions third-party verified
Communities: We Actively Engage People in Tackling the World’s Most Pressing Community and Health Equity Challenges
Our patients, our employees and our business can only thrive when the communities surrounding us are resilient and sustainable. We prioritize addressing health inequities as a core focus of our community impact investments, and we actively seek to increase access to new medicines, improve the underlying social determinants of health that influence health outcomes, and help patients live healthier lives.
- Alnylam Challengers – a Health Equity Community Impact Program
- Alnylam Challengers – International Expansion
- Engaging in Our Communities
- STEM and RNAi Education